RxSight, Inc.
RXST
$5.55
$0.030.54%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -73.56% | 6.76% | 16.71% | -43.91% | -37.93% |
| Total Depreciation and Amortization | -2.00% | -0.35% | 10.05% | -1.15% | 65.61% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -6.82% | 9.47% | -21.15% | 59.95% | 1.19% |
| Change in Net Operating Assets | -441.10% | -66.53% | 272.26% | 83.68% | -76.31% |
| Cash from Operations | -875.90% | 5.98% | 72.87% | 50.45% | -107.32% |
| Capital Expenditure | 33.25% | -95.70% | 62.20% | -167.30% | 32.11% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 213.33% | -0.64% | -152.03% | -24.46% | 888.92% |
| Cash from Investing | 192.03% | -6.77% | -161.45% | -29.74% | 1,479.92% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -177.78% | 147.37% | -533.33% | 76.92% | -8.33% |
| Issuance of Common Stock | -86.36% | 706.11% | -93.67% | 197.13% | -76.71% |
| Repurchase of Common Stock | -23,550.00% | 99.69% | -- | 100.00% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -131.61% | 300.57% | -125.67% | 380.95% | -124.70% |
| Foreign Exchange rate Adjustments | 120.00% | -650.00% | -114.29% | 133.33% | 150.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 75.46% | 9.70% | -186.79% | 9.39% | 46,958.33% |